1Payne DJ Cramp R Bateson J H et al.Rapid identification of metallo-and serine β-lactamases [J].Antimicrob Agen ts Chemother,1994,38:991-991.
2National Committee for Clinical Laboratory Standard 2002. Performance standards for antimicrobial susceptibility testing [S]. NCCLS, Wayne, Pa M2-A7 and MT-AS. 2OO2.
3Winokur P L, Canton R, Casellas J M, et al. Variations in the prevalence of strains expressing an extended-speectrum β-lactamases phenotype and characterization of isolates from Europe, the Americas, and the Western Pacific Region [J]. Clin Infect Dis,2001,32(Suppl 2):s94.
5Palucha A, Mikiewicz B, Hryniewicz W, et al. Concurrent outbreaks of extended-spectrum β-lactamases-producing organisms of the family Enterobacteriaceae in a Warsaw hospital [J]. J Antimicrob Chemother, 1999,44 (4) : 489.
6Champs C D, Sirot D, Chanal C, et al. A 1998 survey of extended-spectrum β-lactamases in Enterobacteriaceae in France [J]. Antimicrob Agents Chemother, 2000,44 (11 ) :3177.
7Spanu T, Luzzaro F, Perilli M, et al. Occurrence of extended-spectrum β-lactamases in members of the family Enterobacteriaceae in Italy : implications for resistance to β-lactams and other antimicrobial drugs [J]. Antimicrob Agents Chemother, 2002,46 (1) : 196.
9Sotto A, De Boever CM, Fabbro- Peray P, et al. Risk factors for antibiotic resistant Escherichia coli isolated from hospitalized patients with urinary tract infections: aprospective study[J]. J Clin- Microbiol, 2001,39 (2) : 438.
10Mikuniya T, Hiraishi T, Maebashi K, et al. Antimierobial activity of fosfomycin under various conditions against standard strains, beta -lactam resistant strains, and muhidrug efllux system mutantsJpn -J - Antibiot[J]. 2005 Apr,58(2) : 105 - 122.
